Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers [PDF]
Background: Adult-onset Still's disease (AOSD) is rare inflammatory disease of unknown etiology that usually affects young adults. The more common clinical manifestations are spiking fevers, arthritis, evanescent rash, elevated liver enzymes ...
Berardicurti O. +13 more
core +1 more source
Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease [PDF]
Adult-onset Still's disease (AOSD) is a rare inflammatory disease of unknown etiology typically characterized by episodes of spiking fever, evanescent rash, arthralgia, leukocytosis, and hyperferritinemia. The pivotal role of interleukin (IL)-1 and other
Baggio, Chiara +4 more
core +1 more source
Recurring Lower Abdominal Pain and Fever as Initial Presentation of Adult Onset Still’s Disease in the Absence of Arthralgia and Other System Involvement [PDF]
A 34 year-old Afro-Caribbean female presented with recurring episodes of fever and lower abdominal pain over a period of two months not improving despite courses of antibiotics for possible recurrent urinary tract infections.
Rajaiah, Nithyananda +2 more
core +7 more sources
Therapy with canakinumab for adult-onset still's disease
Still's disease in children (systemic-onset juvenile idiopathic arthritis, SoJIA) and in adults (adult-onset Still's disease) are considered as non-familial systemic autoinflammatory diseases of unknown etiology driven by similar immunopathogenetic ...
E. L. Nasonov
doaj +1 more source
Adult-onset Still’s disease is a rare inflammatory disorder characterised by fever, arthritis and rash. It can present in a number of ways and is associated in 5% of cases with parenchymal lung involvement.
Robert Perry +4 more
doaj +1 more source
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study [PDF]
To assess the effectiveness of the treatment with high dosage of corticosteroids (CCSs), as first-line therapy, in inducing remission in naïve Adult-onset Still's disease (AOSD) patients compared with low dosage of CCSs, after 6 months.
Berardicurti O. +7 more
core +1 more source
Treatment of adult-onset Still's disease: a review [PDF]
Adult-onset Still's disease (AOSD) is a rare inflammatory disorder that has been recently classified as a polygenic autoinflammatory disorder. The former classification, based on the disease course, seems to be quite dated.
Gerfaud-Valentin, M. +3 more
core +3 more sources
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]
On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P. +4 more
core +2 more sources
Acute liver transplantation in a 41-year-old male patient presenting symptoms of adult-onset Still's disease [PDF]
L
Andrès E. +21 more
core +2 more sources
Ritka betegség, atípusos bőrtünetekkel: felnőttkori Still-betegség = Adult Onset Still’s disease with atypical cutaneous manifestations [PDF]
A felnőttkori Still-betegség a juvenilis reumatoid artritisz ismeretlen etiológiájú, ritka, felnőttkori variánsa. A szerzők egy 62 éves nőbeteg esetét ismertetik, akit intermittáló magas láz, ízületi fájdalmak, maculo-papulosus bőrtünetek, elesett ...
Kása-Kovács, Adrienn, Vajda, Adrienne
core +1 more source

